Genzyme Corporate Genetics Home Search Contact Us Genzyme Websites
Test Menu Health Care Professionals Patients Managed Care Organizations About Genzyme Genetics
Genzyme Genetics

Quick Links:
 Go
 
Search
 Go
Reproductive/Genetics
Overview of Services
Maternal Serum Screening
Carrier Screening
Prenatal Diagnostic Testing
Infertility
Genetic Testing
Genetic Counseling
Medical Education
Risk Assessment
Additional Resources
Current Publications

Prenatal Diagnostic Testing

Genzyme Genetics performs the following:

  • Acetylcholinesterase (AChE) testing
  • Alphafetoprotein (AFAFP amniotic fluid) testing
  • Cytogenetics for:
    - Amniotic fluid
    - Chorionic villi sampling (CVS)
    - Percutaneous umbilical blood sampling (PUBS)
    - Fetal tissue
  • Molecular testing
    - Bloom syndrome mutation analysis
    - Canavan disease mutation analysis
    - Cystic fibrosis expanded mutation analysis – CFplus
    - Familial dysautonomia mutation analysis
    - Fanconi anemia group C mutation analysis
    - Fragile X syndrome mutation analysis
    - Gaucher disease mutation analysis
    - Glycogen storage disease type 1a (GSD1a) mutation analysis
    - Maple syrup urine disease (MSUD) mutation analysis
    - Mucolipidosis type IV mutation analysis
    - Niemann-pick disease type A mutation analysis
    - Rh C/E mutation analysis
    - Rh D mutation analysis
    - Sickle cell anemia mutation analysis
    - Tay-sachs disease mutation analysis
    - Zygosity testing
  • InSight® (Interphase FISH for rapid detection of X, Y, 13, 18, 21)

Cytogenetics

Our cytogenetics program provides detection of chromosome abnormalities for both prenatal and postnatal samples. Our team of board certified geneticists and genetic counselors have in-depth knowledge of cytogenetics and extensive experience with difficult and unusual cases. Our staff is highly skilled in solid tissue cytogenetics and achieves outstanding culture success rates. In addition, we attain greater than 99% culture success rates for amniocentesis, CVS and blood samples.

InSight®

InSight® provides rapid preliminary detection of the most common chromosome aneuploidies in prenatal specimens. It is most useful in cases of extreme urgency (e.g., a pregnancy in which ultrasound abnormalities have been observed) or in cases of high-risk late gestational age. It is standard of care that patients having InSight also have chromosome analysis performed to confirm InSight findings and/or to identify other abnormalities undetectable by InSight.

Prenatal Diagnostic Testing Education Materials

For your convenience, we have posted a PDF of our prenatal diagnosis of chromosome abnormalities physician brochure on this page.

Prenatal Diagnostic Testing Reporting

Every report is reviewed and signed by a board certified clinical cytogeneticist or chemist. Abnormal prenatal and STAT results are immediately telephoned to a referring physician by a board certified clinical cytogeneticist or a genetic counselor. All final reports are telephoned and/or faxed. Test results are also available online for registered users at: www.genzymegoldconnect.com

Search by Test Name or Condition:
  Go
Search by Test Name:
  Go
Related Information

For additional information about our reproductive/genetic testing services, review our detailed brochures.

Carrier Screening and Diagnostic Testing for Ashkenazi Jewish Population (PDF)

CFplusTM - Cystic Fibrosis Mutation Analysis (PDF)

Fragile X Testing (PDF)

Prenatal Diagnosis of Chromosome Abnormalities (PDF)

Maternal Serum Screening (PDF)

Preimplantation Genetic Diagnosis (PGD) (PDF)

GOLD Connect

Login to GOLD Connect
What is GOLD Connect?

  Contact Information

Genzyme Genetics
Tel: (800) 357-5744
Fax: (508) 389-5577

Reproductive/Genetics Client Services
Tel: (800) 848-4436

Shipping information

Terms and Conditions of Use | Privacy Policy | © 2002-2008 Genzyme Corporation. All rights reserved.